parallel import

Founded in 2004, Delfarma is a privately owned pharmaceutical wholesaler and was the first company in Poland to introduce international parallel import of medicinal products from European Economic Area countries.

The EC opines that the parallel import and export of drugs is among legal forms of trade on the unified EU market.

Parallel import or grey product is defined as a non-counterfeit product imported from another country without the permission of the intellectual property owner.

A parallel import, often referred to as grey product, is a non-counterfeit product imported from another country without the permission of the intellectual property owner.

CNBC has reported that the 'parallel import' system allows unauthorised resellers to import and sell foreign vehicles, offering direct competition with the present sales networks of foreign automakers and their China-based partners.

Ralf Zimmermann, general manager Aftersales shared with them the future action plan that Al-Futtaim Motors will put in place, assuring them that the company's priority in 2014 is to combat counterfeit and parallel import of parts into the UAE.

This article does not seek to predict how the government will respond to the IT Pricing Committee's recommendation, nor does it revisit the debates on the merits or otherwise of parallel import restrictions.

There has been a sharp spike in such activity in the last three months, and has prompted some of the mainline dealerships to take out ads highlighting the sanctity of the Commercial Agency Law in the country as well as warning/informing possible car buyers of the downsides to buying a parallel import.

25 June 2013 - Swedish pharmaceutical company Medivir AB (STO:MVIR-B) on Tuesday said it had agreed to sell fully-controlled parallel import arm Cross Pharma AB to Unimedic AB, part of private equity firm MedCap AB, for SEK125m (USD18.7m/EUR14.2m) on a cash and debt free basis.

25 June 2013 a[euro]" Swedish pharmaceutical company Medivir AB (STO:MVIR-B) on Tuesday said it had agreed to sell fully-controlled parallel import arm Cross Pharma AB to Unimedic AB, part of private equity firm MedCap AB, for SEK125m (USD18.7m/EUR14.2m) onA a cash and debt free basis.

This procedure, called parallel import, takes place simultaneously with distribution channels.

The Pharmaceuticals unit contributed some SEK47.6m, which includes Medivir's research and development (R&D) portfolio, and the remainder came from the Parallel import unit in the face of the subsidiary Cross Pharma, which imports, packages and sells original pharmaceuticals.